21st Century Cures Roundtable

Tuesday, May 6, 2014 - 3:00pm
2123 Rayburn
Background Documents and Information: 

On Tuesday, May 6, 2014, at 3 PM , the committee will host thought leaders in the first public discussion regarding the state of biomedical innovation in the United States and what else can be done to accelerate the process of bringing new treatments and cures to patients. Participants will include:

Participants

Dr. Francis Collins
Director of the National Institutes of Health

Dr. Janet Woodcock
Director of FDA’s Center for Drug Evaluation and Research

Dr. Jeff Shuren
Director of FDA’s Center for Devices and Radiological Health

Margaret Anderson
Executive Director of FasterCures

Dr. James Woolliscroft
Dean of the University of Michigan Medical School

Dr. Joe Gray
Associate Director for Translational Research, Knight Cancer Institute, Oregon Health and Science University

Dr. Andrew von Eschenbach
President of Samaritan Health Initiatives Inc.
Chairman of Project FDA at the Manhattan Institute

Dr. Peter Huber
Senior Fellow at the Manhattan Institute

Dr. Ellen Sigal
Chairperson and Founder of Friends of Cancer Research

Sarah Despres
Pew Charitable Trusts

Jonathan Leff
Partner at Deerfield Management
Chairman of the Deerfield Institute

Learn more about 21st Century Cures online here, join the effort on Facebook and Twitter, and contribute to the conversation using #Path2Cures

Opening Statement of Energy and Commerce Committee Chairman Fred Upton

Congress: